Introduction {#s1}
============

How early neuronal connections mature into functional synapses is a key question in neurobiology, and adhesion molecules such as neuroligins (Nlgns) are thought to play important roles in this process ([@bib6]; [@bib17]; [@bib62]). However, there is an ongoing controversy about the function of Nlgns in synaptic differentiation, arising from divergent results obtained using knock-out (KO), knockdown (KD), and overexpression (OE) approaches. Specifically, whereas Nlgn OE or KD bi-directionally affect synapse number, full or conditional Nlgn1/2/3 KO does not alter synapse density ([@bib12]; [@bib14]; [@bib44]; [@bib54]; [@bib65]), suggesting that Nlgns are not generally required for synaptogenesis. To address this apparent conflict, experiments that mixed wild type and Nlgn1 KO neurons suggested the interesting model that neurons might compete with one another for synapse formation, depending on their intrinsic Nlgn1 level ([@bib40]).

Besides the role of Nlgns in controlling synapse number, there is also a debate about the actual function of Nlgns in regulating basal excitatory synaptic transmission and plasticity. Several studies relying on the expression of Nlgn mutants have revealed the potential for Nlgn1 to recruit both NMDA receptors (NMDARs) and AMPA receptors (AMPARs) at synapses through extracellular and intracellular interactions, respectively ([@bib9]; [@bib25]; [@bib30]; [@bib33]; [@bib42]; [@bib47]; [@bib58]). However, constitutive or conditional Nlgn1/2/3 KO selectively affect basal NMDAR-mediated EPSCs and not AMPAR-mediated EPSCs, and rescue experiments with truncated Nlgn1 mutants suggest that the synaptic recruitment of NMDARs requires the intracellular domain of Nlgn1 ([@bib12]; [@bib16]; [@bib37]; [@bib67]). Finally, while it is generally accepted that NMDAR-dependent long-term potentiation (LTP) is impaired by Nlgn1 KD or KO, the issues of which Nlgn1 motifs are important in this process and whether the Nlgn1-NMDAR interaction is required, are unclear ([@bib37]; [@bib38]; [@bib42]; [@bib58]; [@bib67]).

In addition to differences in experimental preparations, these studies relying on the manipulation of the Nlgn expression level all have potential biases, including the compensatory expression of proteins in the case of KO ([@bib20]), off-target effects of inhibitory RNAs ([@bib1]), and mislocalization of overexpressed Nlgns, for example Nlgn1 at inhibitory synapses and Nlgn2 at excitatory synapses ([@bib15]; [@bib42]; [@bib50]; [@bib64]). Furthermore, these techniques operate on a long-term basis, that is days to weeks, due to slow protein turnover. Hence, there is a pressing need for alternative paradigms allowing for an acute control of neuroligin signaling pathways ([@bib35]) without affecting its expression level. Optogenetics is ideally suited for such purpose and was successfully implemented not only to regulate neuronal excitability and homeostasis, but also for fine tuning of protein-protein interactions and signaling pathways in neurons with light ([@bib7]; [@bib13]; [@bib26]; [@bib28]; [@bib46]; [@bib55]; [@bib59]; [@bib68]).

To acutely control Nlgn1 activity, we manipulated the phosphotyrosine level of endogenous Nlgn1 using a photoactivatable receptor tyrosine kinase targeting a unique intracellular tyrosine in Nlgn1 (Y782). This residue belongs to the gephyrin-binding motif and previous experiments showed that unphosphorylated Y782 strongly binds gephyrin - as does a Y782F mutant - while phosphorylated Y782 weakly binds gephyrin, a behavior phenocopied by a Y782A mutant ([@bib25]; [@bib42]). In parallel, neuronal expression of Nlgn1 Y782A (but not Y782F) promotes dendritic spine density and recruitment of PSD-95 and AMPARs ([@bib25]; [@bib42]), suggesting that Nlgn1 tyrosine phosphorylation is responsible for these effects. Here, we report that the stimulation of a light-gated version of the fibroblast growth factor receptor 1 (FGFR1) expressed in hippocampal CA1 neurons increases dendritic spine number as well as AMPAR-receptor-mediated EPSCs, and partially blocks LTP, in a Nlgn1 selective fashion, thus demonstrating a major role of the intracellular tyrosine phosphorylation of endogenous Nlgn1 in post-synaptic differentiation. Together, our results show that not only Nlgn1 is important for regulating dendritic spine number, but also that the Nlgn1 intracellular domain mediates AMPAR recruitment in basal conditions and regulates LTP.

Results {#s2}
=======

Light stimulation of Nlgn1 tyrosine phosphorylation {#s2-1}
---------------------------------------------------

Using an in vitro kinase assay on recombinant GST fused to the intracellular domain of Nlgn1, we previously identified several tyrosine kinases able to directly phosphorylate Nlgn1, including Trk family receptors and the FGFR1 ([@bib42]). To acutely control Nlgn1 phosphorylation independently of endogenous ligand-activated kinases, we thus used here a photoactivatable version of FGFR1 (optoFGFR1) ([@bib29]; [Figure 1A](#fig1){ref-type="fig"}). To show that Nlgn1 can be acutely phosphorylated by optoFGFR1 in a light-dependent manner, we illuminated COS-7 cells co-expressing recombinant Nlgn1 and optoFGFR1 at 470 nm for 15 min using a light emitting diode (LED) array ([Figure 1B](#fig1){ref-type="fig"}). The stimulation of optoFGFR1 by light induced as much Nlgn1 phosphorylation as constitutively active FGFR1 ([Figure 1C,D](#fig1){ref-type="fig"}) (conditions CA and opto+, respectively), indicating potent kinase activation, while samples kept in the dark (conditions light-) did not show significant pTyr levels, revealing no unspecific effect of light. Finally, no phosphorylation of the point mutant Nlgn1-Y782F was observed upon light application ([Figure 1C,D](#fig1){ref-type="fig"}), demonstrating that Y782 is the only tyrosine residue on Nlgn1 which is phosphorylated by light-gated optoFGFR1.

![Optogenetic phosphorylation of Nlgn1 at residue Y782.\
(**A**) Schematic diagram of optogenetically-driven Nlgn1 tyrosine phosphorylation using optoFGFR1. Phosphorylated Nlgn1 is expected to recruit PSD-95 that serves as a platform for trapping AMPARs. (**B**) Scheme representing the 470 LED array that is placed in the incubator and used to illuminate COS-7 cells or organotypic slices contained in a six-well plate. (**C**) pTyr and Nlgn1 immunoblots of proteins extracted from COS-7 cells and immunoprecipitated with anti-Nlgn1 antibodies. Cells expressed either no Nlgn1, Nlgn1 alone, Nlgn1 + constitutively active (CA) FGFR1, Nlgn1 + optoFGFR1, and Nlgn1-Y782F + optoFGFR1. In the first lane, the starting material (SM) from non-transfected cells reveals numerous tyrosine phosphorylated proteins, whereas a single band is present in the Nlgn1 IP samples (black arrowhead). Cells were either kept in the dark (- light), or exposed to alternative 470 nm light and pulses (1 s light pulse every 1 s) for 15 min (+ light). (**D**) Corresponding starting material immunoblotted with HA and FGFR1 antibodies, respectively. The arrowheads represent HA-tagged Nlgn1, HA-tagged optoFGFR1, or constitutively active FGFR1.](elife-52027-fig1){#fig1}

Light activation of optoFGFR1 increases dendritic spine density {#s2-2}
---------------------------------------------------------------

We then examined the impact of triggering Nlgn1 tyrosine phosphorylation on synapse morphology and function in mouse organotypic hippocampal cultures, using confocal microscopy and electrophysiology, respectively ([Figure 2A](#fig2){ref-type="fig"}). Using single-cell electroporation, we expressed optoFGFR1 with a tdTomato volume marker in CA1 neurons of hippocampal slices obtained from either wild type or Nlgn1 KO mice. Immunostained HA-tagged optoFGFR1 was detected throughout dendrites including spines, that is at the right location to phosphorylate Nlgn1 ([Figure 2B](#fig2){ref-type="fig"}). Dendritic spine density increased by \~25% in neurons exposed to 470 nm light pulses for 24 hr, but remained stable in neurons expressing optoFGFR1 and kept in the dark, or in light-stimulated CA1 neurons from Nlgn1 KO slices ([Figure 2C,D](#fig2){ref-type="fig"}), demonstrating that this effect is mediated by light-dependent tyrosine phosphorylation of endogenous Nlgn1.

![Optogenetic stimulation of optoFGFR1 increases dendritic spine density in a Nlgn1-dependent manner.\
(**A**) Experimental procedure to investigate the effect of the optogenetic stimulation of optoFGFR1 on spine density and synaptic transmission. CA1 neurons in organotypic slices from WT or Nlgn1 KO mice were electroporated at DIV 3--5 with tdTomato and HA-tagged optoFGFR1. Two days later, they were either stimulated with alternating blue light for 24 hr or kept in the dark, and processed for imaging or electrophysiology. (**B**) Confocal images of CA1 neurons and dendritic segments showing tdTomato (red) and anti-HA immunostaining (green). (**C**) Confocal images of apical dendrites from electroporated neurons before (0 hr) and 24 hr after light activation of optoFGFR1. Control slices did not receive light, or received light but were from the Nlgn1 KO background. Solid arrowheads point to spines which have appeared, and empty arrowheads to spines which have disappeared in the time interval. (**D**) Normalized spine density for each condition (n = 19--28 dendrites from N = 5--7 cells). Change in spine density was assessed for each condition using paired t-test (\*\*\*p\<0.001, \*p\<0.05, ns: not significant). Spine density change was compared across conditions using a one-way ANOVA followed by Tukey's multiple comparison test (\*\*\*p\<0.001, \*\*p\<0.01).](elife-52027-fig2){#fig2}

Light activation of optoFGFR1 enhances basal AMPAR-, but not NMDAR-mediated EPSCs {#s2-3}
---------------------------------------------------------------------------------

At the electrophysiological level, we measured both AMPAR- and NMDAR-mediated EPSCs evoked by the stimulation of Schaffer's collaterals, comparing neurons expressing optoFGFR1 with paired non-electroporated neighbors by dual patch-clamp recordings ([Figure 3A](#fig3){ref-type="fig"}). Strikingly, neurons expressing optoFGFR1 and exposed to light for 24 hr exhibited \~200% larger evoked AMPAR-mediated EPSCs compared to non-electroporated neighbors that also received light, or to neurons expressing optoFGFR1 and kept in the dark ([Figure 3D,F](#fig3){ref-type="fig"}). This was accompanied by an almost two-fold increase in the frequency of spontaneous AMPAR-mediated EPSCs ([Figure 3B,C](#fig3){ref-type="fig"}), in agreement with the higher number of dendritic spines. No change in the amplitude or kinetics of spontaneous AMPAR-mediated EPSCs was measured ([Figure 3---figure supplement 1A--C](#fig3s1){ref-type="fig"}), indicating that optoFGFR1 activation did not change AMPAR channel conductance. In parallel, there was no significant impact of optoFGFR1 expression and/or light on evoked NMDAR-mediated EPSCs ([Figure 3E,G](#fig3){ref-type="fig"}). Importantly, the light-induced increase AMPAR-mediated EPSCs was not observed in CA1 neurons from Nlgn1 KO slices ([Figure 3D,F](#fig3){ref-type="fig"}), demonstrating that this effect involves the selective tyrosine phosphorylation of Nlgn1. The paired-pulse ratio was not changed by optoFGFR1 expression or light exposure, suggesting that presynaptic function was unaltered ([Figure 3---figure supplement 1D,E](#fig3s1){ref-type="fig"}). Furthermore, although the critical tyrosine residue belonging to the gephyrin-binding motif is conserved in Nlgn2 and Nlgn3 ([@bib53]), where it can also be phosphorylated ([@bib42]), no effect of optoFGFR1 stimulation was observed on inhibitory currents recorded in CA1 neurons ([Figure 3---figure supplement 1F,G](#fig3s1){ref-type="fig"}). Together, these data demonstrate that the phosphorylation mechanism is specific to the Nlgn1 isoform at excitatory post-synapses, and selectively affects AMPAR recruitment at pre-existing or newly formed spines.

![Light activation of optoFGFR1 in CA1 neurons selectively increases AMPA receptor-mediated EPSCs in a Nlgn1-dependent manner.\
(**A**) Dual patch-clamp recordings of AMPAR- and NMDAR-mediated currents upon stimulation of Schaffer's collaterals were made at holding potentials of −70 and +40 mV (respectively) in electroporated neurons and non-electroporated counterparts. The image shows two patched neurons in the CA1 area, the brighter one expressing optoFGFR1 + tdTomato. (**B**) Representative electrophysiological recordings of spontaneous AMPAR-mediated EPSCs (sEPSCs) in a control non-electroporated neuron (black trace), and a paired neuron expressing optoFGFR1 and pre-exposed to light for 24 hr (blue trace). (**C**) Corresponding sEPSC frequency for control neurons and neurons expressing optoFGFR1. Data were compared using the Wilcoxon matched-pairs signed rank test (\*p\<0.05). (**D, E**) Scatter plots of AMPAR- and NMDAR-mediated EPSCs, respectively, in neurons expressing optoFGFR1 compared to paired unelectroporated neurons (control cell), in the indicated conditions. Representative traces (color) normalized to control (grey) are shown as insets. (**F, G**) Average of AMPAR- and NMDAR-mediated EPSCs in the three conditions, normalized to the control (100%). Data were compared to the control condition by the Wilcoxon matched-pairs signed rank test, and between themselves using one-way ANOVA followed by Tukey\'s multiple comparison (\*\*p\<0.01, \*p\<0.05, ns: not significant).](elife-52027-fig3){#fig3}

The intracellular Y782 residue is involved in light-induced effects {#s2-4}
-------------------------------------------------------------------

To verify that optoFGFR1 was specifically phosphorylating the Nlgn1 Y782 residue in neurons, we adopted a replacement strategy ([@bib42]) by co-electroporating opto*Fgfr1*, *Nlgn1*-shRNA, and *Nlgn1* rescue constructs in slices from WT mice ([Figure 4A,B](#fig4){ref-type="fig"}). This led to basal AMPAR- and NMDAR-mediated EPSCs in the dark matching those measured in paired non-electroporated neurons expressing endogenous Nlgn1 levels ([Figure 4C--F](#fig4){ref-type="fig"}). In parallel, the density of dendritic spines remained stable over time in neurons expressing optoFGFR1 and kept in the dark, or not expressing optoFGFR1 and exposed to light, indicating no side effects of either optoFGFR1 electroporation or photo-stimulation ([Figure 4---figure supplement 1](#fig4s1){ref-type="fig"}). In CA1 neurons expressing rescue Nlgn1-WT and optoFGFR1, light exposure induced again a \~25% increase in dendritic spine number ([Figure 4---figure supplement 1](#fig4s1){ref-type="fig"}), as well as a \~200% increase in AMPAR (but not NMDAR) -mediated EPSCs compared to control non-electroporated neurons ([Figure 4C--F](#fig4){ref-type="fig"}). These effects were similar to those found in neurons expressing endogenous Nlgn1 ([Figures 2](#fig2){ref-type="fig"} and [3](#fig3){ref-type="fig"}), validating the Nlgn1 replacement strategy. Importantly, the increase in spine density and AMPAR-mediated EPSCs by optoFGFR1 activation was not observed in CA1 neurons expressing Nlgn1-Y782F ([Figure 4C,E](#fig4){ref-type="fig"} and [Figure 4---figure supplement 1](#fig4s1){ref-type="fig"}), indicating that those effects are mediated by phosphorylation of the Nlgn1 Y782 residue induced by the photo-activation of optoFGFR1.

![The light-induced increase in AMPA receptor-mediated EPSCs is specific to Y782 phosphorylation in Nlgn1.\
CA1 Neurons were co-electroporated with plasmids encoding tdTomato, shRNA against endogenous *Nlgn1* containing a GFP reporter, shRNA resistant AP-tagged *Nlgn1*-WT or -Y782F, biotin ligase (BirA^ER^), and HA-tagged opto*Fgfr1*. (**A, B**) Confocal images showing tdTomato (red) and GFP (green). Biotinylated Nlgn1 and optoFGFR1 were stained in different slices using streptavidin-Atto647 and anti-HA antibody, respectively (magenta). (**C, D**) Scatter plots of AMPAR- and NMDAR-mediated EPSCs, respectively, for electroporated versus paired non-electroporated neurons (control cell) in the indicated conditions. Representative traces (black, blue or violet) normalized to control (grey) are shown as insets. (**E, F**) Average of AMPAR-and NMDAR-mediated EPSCs, respectively, normalized to the control (100%) in the different conditions. Data were compared to the control condition by the Wilcoxon matched-pairs signed rank test and between themselves using one-way ANOVA followed by Tukey\'s multiple comparison (\*\*p\<0.01, ns: not significant).](elife-52027-fig4){#fig4}

Light activation of Nlgn1 tyrosine phosphorylation impairs LTP {#s2-5}
--------------------------------------------------------------

Finally, we asked whether the increase of basal AMPAR-mediated currents induced by Nlgn1 phosphorylation could partially occlude NMDAR-dependent long term potentiation (LTP). Using a pairing protocol, we induced an increase of about threefold in evoked AMPAR-mediated EPSCs, which was blocked by the NMDAR antagonist AP5 ([Figure 5---figure supplement 1A](#fig5s1){ref-type="fig"}). CA1 neurons expressing optoFGFR1 and pre-exposed to light showed a significant \~50% reduction in the LTP plateau level compared to control non-electroporated neighbors ([Figure 5A,B](#fig5){ref-type="fig"}). To check if this effect was again specific of Nlgn1, we performed LTP experiments in hippocampal slices from Nlgn1 KO mice. Surprisingly, the LTP level was barely reduced ([Figure 5A,C](#fig5){ref-type="fig"}), despite a significant decrease in NMDA/AMPA ratio in control non-electroporated Nlgn1 KO neurons compared to neurons from WT mice ([Figure 5---figure supplement 1B](#fig5s1){ref-type="fig"}; [@bib9]; [@bib16]). However, light stimulation of optoFGFR1 did not alter LTP in Nlgn1 KO neurons ([Figure 5C,D](#fig5){ref-type="fig"}), indicating that Nlgn1 phosphorylation is responsible for the decreased LTP in wild-type neurons.

![Light activation of Nlgn1 phosphorylation by optoFGFR1 reduces LTP.\
(**A**) Average AMPAR-mediated EPSCs in CA1 neurons expressing optoFGFR1 (blue circles) or in non-electroporated neighbors (grey circles), all pre-exposed to light for 24 hr, upon LTP induction at time 0 using a pairing protocol. Sample traces are shown at time 0 and 30 min after LTP induction. The solid lines show averages from 10 computer simulations for each condition with parameters k~on~ = 1 s^−1^ (black) or 3 s^−1^ (blue), and k~off~ drops from 0.04 to 0.004 s^−1^. (**B**) Individual values of the long-term plateau of AMPAR-mediated EPSC in the two conditions (6--10 min after LTP induction), expressed as a percentage of the baseline level. Data were compared to the control condition (unelectroporated neuron also exposed to light) by Wilcoxon matched-pairs signed rank test (\*\*\*p\<0.001). (**C, D**) Similar LTP recordings and quantification in CA1 neurons from Nlgn1 KO slices, with corresponding simulations (red line, k~on~ = 1 s^−1^ and k~off~ drops from 0.04 to 0.008 s^−1^). Data were compared to the control condition (unelectroporated neuron also exposed to light) by Wilcoxon matched-pairs signed rank test (ns: non-significant).](elife-52027-fig5){#fig5}

Quantitative interpretation of LTP data by modeling AMPAR trapping at synapses {#s2-6}
------------------------------------------------------------------------------

To quantitatively interpret those LTP results, we carried out computer simulations describing membrane diffusion and synaptic trapping of individual AMPARs ([Figure 6A](#fig6){ref-type="fig"}, [Figure 6---figure supplement 1A,B](#fig6s1){ref-type="fig"} and Supplementary source code), based on a previous framework using realistic kinetic parameters ([@bib18]). This model is in line with experiments showing that hippocampal LTP primarily involves the capture of extra-synaptic AMPARs ([@bib27]; [@bib52]). We mimicked LTP by introducing a step decrease in the apparent off-rate between AMPARs and the PSD scaffold ([Figure 6B,C](#fig6){ref-type="fig"}). The simulations matched very well experimental LTP ([Figure 5A,C](#fig5){ref-type="fig"}), both in terms of kinetics and plateau value (\~270%), supporting this diffusion/trap model. To mimic the effect of Nlgn1 phosphorylation on postsynaptic density (PSD) assembly and AMPAR recruitment ([@bib42]), we raised the AMPAR/scaffold binding rate, resulting in a \~2 fold increase of basal synaptic AMPAR number ([Figure 6---figure supplement 1C](#fig6s1){ref-type="fig"}) reproducing the experimental data ([Figure 3D,F](#fig3){ref-type="fig"}). In response to the same LTP simulation, the relative increase in AMPAR number now reached only \~190%, as in optoFGFR1 experiments ([Figure 5A](#fig5){ref-type="fig"}). Thus, the partial occlusion of LTP observed upon optoFGFR1 stimulation can be explained by a high initial recruitment of synaptic AMPARs, which depletes the extra-synaptic AMPAR reservoir necessary for LTP. Accordingly, we previously reported an almost complete occlusion of LTP upon replacement of endogenous Nlgn1 by a Y782A mutant which phenocopies maximally phosphorylated Nlgn1 and increases AMPAR-mediated EPSCs by \~4 fold ([@bib25]; [@bib42]). Overall, our model predicts a negative correlation between basal synaptic AMPAR number and the ability to respond to LTP ([Figure 6---figure supplement 1D](#fig6s1){ref-type="fig"}), that perfectly fits the experiments ([Figure 6D](#fig6){ref-type="fig"}). These data suggest that Nlgn1 tyrosine phosphorylation impairs LTP by promoting high initial synaptic AMPAR levels.

![Modeling LTP experiments.\
(**A**) Schematic diagram of the AMPAR diffusion/trap process, with model parameters being indicated in italic. (**B**) Heat maps representing simulations of AMPAR accumulation at a single synapse over time. LTP is mimicked by decreasing the AMPAR/scaffold off-rate, causing a diffusional trapping of AMPARs from extra-synaptic pools. Nlgn1 phosphorylation is mimicked by increasing the initial AMPAR/scaffold on-rate, resulting in higher basal AMPAR level and lower LTP (relatively to baseline). (**C**) Graph showing the relative change in synaptic AMPAR content (in % of baseline) over time, when LTP is simulated by a drop in k~off~ from 0.04 to 0.004 s^−1^ at time zero. Curves correspond to different values of the parameter k~on~ ranging from 0.05 to 8 s^−1^. (**D**) Relationship between basal synaptic AMPAR content and LTP plateau level (% of baseline). Experimental points (circles) were obtained from non-electroporated neurons (grey), neurons expressing opoFGFR1 and stimulated with light (blue), or neurons co-expressing shRNA to Nlgn1 and either Nlgn1-WT (light blue) or Nlgn1-Y782A (dark blue) data taken from [@bib42]. Basal AMPAR-mediated EPSCs were normalized to match a synaptic level of 33 AMPARs in the control condition ([@bib43]). The solid line represents simulated data generated by varying the AMPAR/scaffold binding rate from 0.1 to 10 s^−1^.](elife-52027-fig6){#fig6}

Discussion {#s3}
==========

Orthogonal to the traditional paradigms used to manipulate Nlgn expression level or replace Nlgn isoforms with truncated or mutated versions, this novel optogenetic approach allows for a fine tuning of the tyrosine phosphorylation of endogenous Nlgn1, revealing a strong role of Nlgn1 intracellular signaling in excitatory post-synapse differentiation. Our results show that Nlgn1 tyrosine phosphorylation specifically regulates dendritic spine number, mediates AMPAR recruitment in basal conditions, and impairs LTP.

Together, our results support a mechanism by which, in its tyrosine phosphorylated state, Nlgn1 preferentially recruits intracellular PDZ domain containing scaffolding proteins including PSD-95 ([@bib25]; [@bib36]), associated with a morphological stabilization of dendritic spines ([@bib10]) and serving as slots for the diffusional trapping of surface AMPARs ([@bib19]; [@bib30]; [@bib47]). In contrast, NMDAR-mediated EPSCs are not affected by Nlgn1 phosphorylation, supporting the concept of a direct extracellular coupling between Nlgn1 and GluN1 ([@bib9]; [@bib58]). The selective effects of endogenous Nlgn1 tyrosine phosphorylation on dendritic spine density, AMPAR-receptor-mediated EPSCs, and LTP are in close agreement with our previous observations based on the KD plus rescue of Nlgn1 point mutants, in particular the Nlgn1 Y782A mutant, which promotes synaptic recruitment of PSD-95, strongly enhances basal AMPAR-mediated EPSCs, and totally blocks LTP through synapse unsilencing mechanisms ([@bib42]). The increase in frequency - but not amplitude - of spontaneous AMPAR-mediated EPSCs upon optoFGFR1 stimulation indicates the formation of synapses containing a fixed bolus of AMPARs. Importantly, optogenetic Nlgn1 phosphorylation induces a similar response as PSD-95 overexpression by increasing spine density, enhancing AMPAR- but not NMDAR-dependent transmission, and occluding LTP ([@bib22]; [@bib23]; [@bib60]), which further supports our model. Conversely, unphosphorylated Nlgn1 (as mimicked by the Y782F mutant) might associate instead with gephyrin clusters shown to dynamically appear and disappear on the sides of dendritic spines ([@bib66]). Thus, by locally controlling Nlgn1 phosphorylation, a single spine might have the possibility to assemble either excitatory or inhibitory scaffolding nanomodules ([@bib30]; [@bib34]; [@bib63]).

Our computer simulations of AMPAR diffusional trapping at PSDs provide a simple framework to interpret the experimental data. By avoiding gephyrin binding and instead triggering PSD scaffold assembly, Nlgn1 tyrosine phosphorylation provides synapses with fresh surface-diffusing AMPARs. These already potentiated (or unsilenced) synapses are thus less prone to respond to the LTP stimulation, because extra-synaptic pools of AMPARs have been consequently depleted ([@bib27]; [@bib52]). A strong role of Nlgn1/PSD-95 interaction in synaptic function is also supported by a recent study showing that PKA-mediated phosphorylation of the S839 residue located near the C-terminal PDZ domain binding motif dynamically regulates PSD-95 binding, affecting both dendritic spine number and AMPAR-mediated miniature EPSCs ([@bib36]).

Although the tyrosine residue in Nlgn1 belongs to a gephyrin-binding motif which is highly conserved among the other Nlgn isoforms and controls gephyrin binding ([@bib25]; [@bib53]), optoFGFR1 stimulation did not affect evoked inhibitory currents, suggesting that the phosphorylation of Nlgn2 or Nlgn3 either did not occur, or did not modify the recruitment of the gephyrin scaffold and associated GABA~A~ receptors. The lack of effects of optoFGFR1 stimulation in neurons from Nlgn1 KO slices confirms that it is indeed Nlgn1 phosphorylation which is causing the observed increases in dendritic spine density and AMPAR-mediated EPSCs. It might be interesting to apply similar optogenetic approaches to control the phosphorylation of other intracellular Nlgn1 residues including S839 and T709 by engineering photoactivatable versions of PKA and CamKII, respectively ([@bib4]; [@bib36]), or inhibitors of those kinases ([@bib48]), expecting to alter Nlgn1 trafficking and thereby synaptic function and potentiation. Other phosphorylation sites have been reported in Nlgn2 and Nlgn4 which might also be interesting to target with such light-gated kinases ([@bib2]; [@bib5]).

Because optoFGFR1 is lacking a ligand-binding domain, its light-activation is expected to by-pass the endogenous regulation of Nlgn1 tyrosine phosphorylation, which involves the Trk family of tyrosine kinases ([@bib42]) that are responding to intrinsic ligands (BDNF and NGF) ([@bib32]). Photoactivatable versions of Trks have been reported and their stimulation with light for 48 hr induces neurite outgrowth in DIV1-3 dissociated neurons and de novo formation of axonal filopodia within 30 min ([@bib13]), but the effects on spine formation and synaptic transmission in mature neurons have not been measured yet. Short-term photoactivation of another tyrosine kinase, EphB2, leads within seconds to the retraction of non-stabilized dendritic filopodia ([@bib46]) and within minutes to the induction of new filopodia by activating actin polymerization ([@bib45]). Those effects are likely to obey different downstream signaling pathways than the ones we report here and which highly depend on Nlgn1 and the associated PSD scaffold.

Our data demonstrating the critical role of a single tyrosine residue located in the middle of the intracellular motif are difficult to reconcile with a previous report showing that a Nlgn3 construct with a 77-aa intracellular truncation (thus removing the motif containing the tyrosine) can still rescue AMPAR-mediated synaptic transmission upon Nlgn1/2/3 KD ([@bib57]). Moreover, whereas Nlgn1 KO was shown to affect primarily basal NMDAR-mediated synaptic transmission, we find instead strong effects of acute Nlgn1 tyrosine phosphorylation on basal AMPAR-mediated EPSCs, and no alteration of NMDAR-dependent EPSCs. The fact that AMPAR-mediated EPSCs are not altered in the Nlgn1 KO ([@bib12]) may result from the compensatory expression of scaffolding or adhesion molecules, in particular Nlgn3 ([@bib20]), which also interacts with PSD-95. This would explain the fact that a dual Nlgn1/3 (and triple Nlgn1/2/3) KO are required to alter AMPARs levels and AMPAR-mEPSCs in cultured neurons ([@bib12]). In contrast, a compensatory expression of Nlgn3 which does not interact extracellularly with NMDARs ([@bib9]; [@bib58]) is not expected to rescue the decrease in NMDAR-EPSCs caused by Nlgn1 KO.

Finally, increasing the Nlgn1 phosphorylation by optoFGFR1 activation reduced LTP, as did the expression of the non-phosphorylatable Nlgn1-Y782F mutant ([@bib42]), suggesting that an optimal level of intracellular Nlgn1 tyrosine phosphorylation is necessary to elicit normal LTP. In contrast, another study found that LTP is impaired in acute slices from Nlgn1/2/3 cKO and can be rescued upon expression of a GPI-anchored Nlgn1 lacking the entire intracellular domain ([@bib67]), and thus the C-terminal PDZ domain binding motif which we find important for anchoring AMPARs through PSD-95 ([@bib42]; [@bib47]). Moreover, we did not find a significant decrease of LTP in neurons from constitutive Nlgn1 KO, in contrast to previous reports ([@bib9]; [@bib37]; [@bib38]; [@bib58]). While the differences might come from the use of different experimental preparations (acute vs organotypic slices), LTP stimulation protocols, and perturbation approaches (KD or KO, each with specific timing with respect to the synaptogenesis period), we believe that our approach allowing for an acute control of a signaling mechanism associated with endogenous Nlgn1, demonstrates a strong role of the Nlgn1 intracellular domain in synaptic function. Besides clarifying the role of Nlgn1 at excitatory synapses, the optogenetic phosphorylation of Nlgn1 provides the exciting opportunity to control in time and space synaptic connectivity and function, and has therefore a great potential for investigating the causality between synaptic plasticity and learning processes as well as the possible contribution of Nlgns to neuropsychiatric behaviors ([@bib8]).

Materials and methods {#s4}
=====================

  -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Reagent type (species)\                      Designation                                               Source or reference                                                            Identifiers                                                                                                                          Additional information
  or resource                                                                                                                                                                                                                                                                                                                
  -------------------------------------------- --------------------------------------------------------- ------------------------------------------------------------------------------ ------------------------------------------------------------------------------------------------------------------------------------ ----------------------------------------------------------------------------------------------------------------------
  Gene (*Mus musculus*)                        *Nlgn1*                                                   NCBI                                                                           NM_138666.4                                                                                                                          

  Gene (*Mus musculus*)                        *Fgfr1*                                                   NCBI                                                                           [NM_010206.3](https://www.ncbi.nlm.nih.gov/nucleotide/NM_001079908.2?report=genbank&log%24=nuclalign&blast_rank=1&RID=5X3NJ2XG016)   

  Strain, strain background (*Mus musculus*)   C57Bl/6J                                                  Charles River                                                                  RRID:[IMSR_JAX:000664](https://scicrunch.org/resolver/IMSR_JAX:000664)                                                               

  Genetic reagent (*Mus musculus*)             Nlgn1-KO                                                  [@bib65] (PMID:[16982420](https://www.ncbi.nlm.nih.gov/pubmed/16982420))       RRID:[MGI:3688627](https://scicrunch.org/resolver/MGI:3688627)                                                                       N. Brose (MPI Goettingen)\
                                                                                                                                                                                                                                                                                                                             C57Bl/6J background

  Cell line (*Simian*)                         COS-7                                                     ATCC                                                                           RRID:[CVCL_0224](https://scicrunch.org/resolver/CVCL_0224)                                                                           

  Biological sample (*Mus muscumus*)           Organotypic slices (350 µm)                               This paper\                                                                                                                                                                                                         Prepared from P5-P8 animals.\
                                                                                                         [@bib61] (PMID:[1715499](https://www.ncbi.nlm.nih.gov/pubmed/1715499))                                                                                                                                              From C57Bl/6J WT or Nlgn1-KO mice

  Transfected construct *Mus musculus*         *HA-Nlgn1*                                                P. Scheiffele (Biozentrum, Basel)                                                                                                                                                                                   In COS cells with X-TremeGENE kit

  Transfected construct *Mus musculus*         *Fgfr1 V561M-FLAG (CA)*                                   This paper                                                                                                                                                                                                          Obtained with In-Fusion HD Cloning Kit using *Fgfr1-V561M-F* and *Fgfr1-V561M-R* primers on the Fgfr1-Flag plasmid.\
                                                                                                                                                                                                                                                                                                                             In COS cells

  Transfected construct *Mus musculus*         *optoFgfr1-HA*                                            [@bib29]\                                                                      (RRID:[Addgene_58745](https://scicrunch.org/resolver/Addgene_58745)                                                                  In COS cells with X-TremeGENE kit.\
                                                                                                         (PMID:[24986882](https://www.ncbi.nlm.nih.gov/pubmed/24986882))                                                                                                                                                     In organotypic slices by single cell electroporation.

  Transfected construct *Mus musculus*         *HA-Nlgn1 Y782F*                                          [@bib25]\                                                                                                                                                                                                           In COS cells with X-TremeGENE kit.
                                                                                                         (PMID:[23770246](https://www.ncbi.nlm.nih.gov/pubmed/23770246))                                                                                                                                                     

  Transfected construct (*Synthetic*)          *tdTomato*                                                R. Tsien (UC San Diego, CA)                                                                                                                                                                                         In organotypic slices by single cell electroporation.

  Transfected construct (*M. musculus*)        *Nlgn1 -shRNA* (targeting Nlgn1)                          [@bib14]\                                                                      RRID:[Addgene_59339](https://scicrunch.org/resolver/Addgene_59339)                                                                   Gift from P. Scheiffele\
                                                                                                         (PMID:[15681343](https://www.ncbi.nlm.nih.gov/pubmed/15681343))                                                                                                                                                     In organotypic slices by single cell electroporation.

  Transfected construct (*M. musculus*)        *AP-Nlgn1 rescue* (shRNA resistant)                       [@bib11]\                                                                                                                                                                                                           In organotypic slices by single cell electroporation.
                                                                                                         (PMID:[26979420](https://www.ncbi.nlm.nih.gov/pubmed/26979420))                                                                                                                                                     

  Transfected construct (*M. musculus*)        *AP-Nlgn1 Y782F rescue* (shRNA resistant)                 [@bib42]\                                                                                                                                                                                                           In organotypic slices by single cell electroporation.
                                                                                                         (PMID:[30266896](https://www.ncbi.nlm.nih.gov/pubmed/30266896))                                                                                                                                                     

  Transfected construct (*M. musculus*)        *BirA^ER^*                                                A. Ting (Stanford University, CA)                                                                                                                                                                                   

  Recombinant DNA reagent (*M. musculus*)      *Fgfr1-Flag* plasmid                                      [@bib21]\                                                                                                                                                                                                           L. Duchesne (Université de Rennes)
                                                                                                         PMID:[16829530](https://www.ncbi.nlm.nih.gov/pubmed/16829530)                                                                                                                                                       

  Sequence-based reagent                       Primers *Fgfr1-V561M-F; Fgfr1-V561M-R*                    This paper\                                                                                                                                                                                                         *TGTCATTATGGAGTACGCCTC;*\
                                                                                                         From Eurogentec                                                                                                                                                                                                     *TACTCCATAATGACATAAAGAGG*

  Antibody                                     anti-Nlgn1 (Rabbit polyclonal)                            Synaptic systems 129013                                                        RRID:[AB_2151646](https://scicrunch.org/resolver/AB_2151646)                                                                         IP (2 µg)\
                                                                                                                                                                                                                                                                                                                             WB (1:1000)

  Antibody                                     anti-phosphotyrosine P-Tyr-100 (Mouse monoclonal)         Cell Signaling Technology 9411                                                 RRID:[AB_331228](https://scicrunch.org/resolver/AB_331228)                                                                           WB (1:1000)

  Antibody                                     anti-FGFR1 (monoclonal polyclonal)                        Cell Signaling Technology D8E4\                                                RRID:[AB_11178519](https://scicrunch.org/resolver/AB_11178519)                                                                       WB (1:1000)
                                                                                                         9740                                                                                                                                                                                                                

  Antibody                                     anti-HA\                                                  Roche 3F10\                                                                    RRID:[AB_390918](https://scicrunch.org/resolver/AB_390918)                                                                           WB (1:1000)\
                                               (Rat monoclonal)                                          11867423001                                                                                                                                                                                                         IHC (1:100)

  Antibody                                     Easyblot HRP antibodies anti-mouse;anti-rabbit            GeneTex\                                                                       RRID:[AB_10728926](https://scicrunch.org/resolver/AB_10728926); RRID:[AB_10620421](https://scicrunch.org/resolver/AB_10620421)       WB (1:1000)
                                                                                                         GTX221667-01;GTX221666-01                                                                                                                                                                                           

  Antibody                                     Alexa647-conjugated anti-rat antibody (Goat Polyclonal)   Molecular Probes\                                                              RRID:[AB_141778](https://scicrunch.org/resolver/AB_141778)                                                                           IHC (1:200)
                                                                                                         A21247                                                                                                                                                                                                              

  Peptide, recombinant protein                 NeutrAvidin                                               Invitrogen                                                                     A2666                                                                                                                                IHC (1:200)

  Commercial assay or kit                      In-Fusion HD Cloning Kit                                  Takara Bio                                                                     639642 (Ozyme)                                                                                                                       In COS cells

  Commercial assay or kit                      X-tremeGENE HP DNA Transfection Reagent                   Roche\                                                                         6366546001                                                                                                                           
                                                                                                         (RRID:[SCR_001326](https://scicrunch.org/resolver/SCR_001326))                                                                                                                                                      

  Commercial assay or kit                      Dynabeads Protein G                                       Thermo Fisher Scientific\                                                      10004D                                                                                                                               For immunoprecipitation
                                                                                                         (RRID:[SCR_008452](https://scicrunch.org/resolver/SCR_008452))                                                                                                                                                      

  Chemical compound, drug                      D-AP5                                                     TOCRIS (RRID:[SCR_003689](https://scicrunch.org/resolver/SCR_003689))          0106/10                                                                                                                              50 µM

  Chemical compound, drug                      Bicuculline                                               TOCRIS (RRID:[SCR_003689](https://scicrunch.org/resolver/SCR_003689))          0130/50                                                                                                                              20 µM

  Chemical compound, drug                      NBQX                                                      TOCRIS (RRID:[SCR_003689](https://scicrunch.org/resolver/SCR_003689))          0373/10                                                                                                                              100 nM or 10 µM

  Chemical compound, drug                      NHS-ester ATTO 647N                                       ATTO-TEC GmbH                                                                  AD 647 N-31                                                                                                                          

  Software, algorithm                          Metamorph                                                 Molecular Devices                                                              RRID:[SCR_002368](https://scicrunch.org/resolver/SCR_002368)                                                                         

  Software, algorithm                          GraphPad                                                  PRISM                                                                          RRID:[SCR_002798](https://scicrunch.org/resolver/SCR_002798)                                                                         

  Software, algorithm                          Clampex                                                   Axon Instruments                                                                                                                                                                                                    

  Software, algorithm                          Clampfit                                                  Axon Instruments                                                                                                                                                                                                    

  Software, algorithm                          Minianalysis                                              Synaptosoft                                                                    RRID:[SCR_002184](https://scicrunch.org/resolver/SCR_002184)                                                                         

  Software, algorithm                          FluoSim                                                   [@bib41]\                                                                                                                                                                                                           Full source code will be\
                                                                                                         (DOI:[10.1101/2020.02.06.937045](https://doi.org/10.1101/2020.02.06.937045))                                                                                                                                        deposited on GitHub\
                                                                                                                                                                                                                                                                                                                             upon paper acceptance
  -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Constructs {#s4-1}
----------

Plasmids for BirA^ER^ and AP-*Nlgn1* harboring both extracellular splice inserts A and B were kind gifts from A. Ting (Stanford University, CA). Short hairpin RNA to murine *Nlgn1* (sh*Nlgn1*) was a generous gift from P. Scheiffele (Biozentrum, Basel). shRNA-resistant AP-tagged *Nlgn1* and *Nlgn1-*Y782F were described previously ([@bib11]; [@bib42]). The tdTomato plasmid was a generous gift from R. Tsien (UC San Diego, CA). *Fgfr1*-Flag ([@bib21]) was a generous gift from L. Duchesne (Université de Rennes). To generate constitutively active (CA) *Fgfr1*-Flag, the V561M mutation was introduced using the In-Fusion HD Cloning Kit (Takara Bio) and the following primers: *Fgfr1*-V561M-F 5'TGTCATTATGGAGTACGCCTC3' and *Fgfr1*-V561M-R 5'TACTCCATAATGACATAAAGAGG3'. Opto*Fgfr1* bearing an N-terminal myristoylation motif to attach to the membrane, and a C-terminal HA-tag was described previously ([@bib29]). In this construct, the extracellular FGF binding domain has been removed, and a light-oxygen voltage sensing (LOV) domain is fused to the C-terminus, such that stimulation with blue light induces dimerization of the FGFR1 intracellular domain and subsequent kinase activation in a ligand-independent manner.

COS-7 cell culture and transfection {#s4-2}
-----------------------------------

COS-7 cells purchased from ATCC (cell line source ECACC 87021302) were cultured in DMEM (Eurobio) supplemented with 2 mM glutamax (GIBCO), 1 mM [sodium pyruvate](http://www.sciencedirect.com/topics/page/Sodium_pyruvate) (Sigma-Aldrich), and 10% [Fetal Bovine Serum](http://www.sciencedirect.com/topics/page/Fetal_bovine_serum) (Eurobio). COS-7 cells used in this study were regularly tested negative for Mycoplasma using the MycoAlertTM Detection Kit (LT07-218) from Lonza. For IP experiments, cells were plated in 6-well plates at a density of 120,000 per well. After 1 day, cells were [transfected](http://www.sciencedirect.com/topics/page/Transfection) with 10:1 combinations of Nlgn1 and FGFR1 DNA constructs using the X-TremeGENE kit (Roche), with 1 µg total DNA for 2 µL reagent in 100 µL PBS per well. Cells were left under a humidified 5% CO~2~ atmosphere (37°C) for 2 days before being processed for biochemistry.

Organotypic slice culture {#s4-3}
-------------------------

Organotypic hippocampal slice cultures were prepared as described ([@bib61]) from either wild type or Nlgn1 knock-out mice (C57Bl/6J strain) obtained from N. Brose (MPI Goettingen). Animals were raised in our animal facility and were handled and killed according to European ethical rules. Briefly, animals at postnatal days 5--8 were quickly decapitated and brains placed in ice-cold Gey's balanced salt solution under sterile conditions. Hippocampi were dissected out and coronal slices (350 µm) were cut using a tissue chopper (McIlwain) and incubated at 35°C with serum-containing medium on Millicell culture inserts (CM, Millipore). The medium was replaced every 2--3 days.

LED illumination {#s4-4}
----------------

For cells expressing optoFGFR1, all steps before biochemical, confocal, or electrophysiological analysis were done in the dark. COS-7 cells or organotypic hippocampal slices were exposed to light pulses of 1 s every other second for 15 min or 24 hr, respectively, by placing the six-well plates under a custom-made rectangular array comprising 8 × 12 light emitting diodes (LEDs) (470 nm, 15 mW each), powered by a 24 V DC supply, and driven by an internal Arduino Leonardo pulse generator. The array was covered with a 5-mm-thick white Plexiglas sheet to dim the emitted light power by \~100 fold (2.5 µW/mm²).

Immuno-precipitation, SDS--PAGE, and immunoblotting {#s4-5}
---------------------------------------------------

COS-7 cells were treated with 10 µM pervanadate for 15 min before lysis to preserve phosphate groups on Nlgn1. Whole-cell protein extracts were obtained by solubilizing cells in lysis buffer (50 mM HEPES, pH 7.2, 10 mM EDTA, 0.1% SDS, 1% NP-40, 0.5% DOC, 2 mM Na-Vanadate, 35 µM PAO, 48 mM Na-Pyrophosphate, 100 mM NaF, 30 mM phenyl-phosphate, 50 µM NH~4~-molybdate and 1 mM ZnCl~2~) containing protease Inhibitor Cocktail Set III, EDTA-Free (Calbiochem). Lysates were clarified by centrifugation at 8000 × g for 15 min. Equal amounts of protein (500 µg, estimated by Direct Detect assay, Merck Millipore) were incubated overnight with 2 µg rabbit anti-Nlgn1 (Synaptic systems 129013), then precipitated with protein G beads (Dynabeads Protein G, Thermo Fisher Scientific) and washed four times with lysis buffer. At the end of the immunoprecipitation, 20 µL beads were resuspended in 20 µL of 2x loading buffer (120 mM Tris-HCl, 3% SDS, 10% glycerol, 2% β-mercaptoethanol, 0.02% bromophenol blue, pH = 6.8). After magnetic beads isolation, half of the supernatants or starting materials (10--20 µg) were separated on 4--15% Mini-PROTEAN TGX Precast Protein Gels (Bio-Rad) and transferred to nitrocellulose membranes for immunoblotting (semi-dry, 7 min, Bio-Rad). After blocking with 5% non-fat dried milk in Tris-buffered saline Tween-20 (TBST; 28 mM Tris, 137 mM NaCl, 0.05% Tween-20, pH 7.4) for 45 min at room temperature, membranes were probed for 1 hr at room temperature or overnight at 4°C with mouse anti-phosphotyrosine (1:1000, Cell Signaling Technology 9411S), rabbit anti-Nlgn1 (1:1000, Synaptic systems 129013), rabbit anti-FGFR1 (1:1000, Cell Signaling Technology D8E4), or rat anti-HA (1:1000, Roche 3F10). After washing three times with TBST buffer, blots were incubated for 1 hr at room temperature with the corresponding horseradish peroxidase (HRP)--conjugated goat secondary antibodies (1:5000, Jackson Immunoresearch) for input samples, or Easyblot HRP antibodies (GeneTex) for IP samples. The latter was used to avoid the detection of primary antibodies from the IP. Target proteins were detected by chemiluminescence with Super signal West Femto (Pierce) on the ChemiDoc Touch system (Bio-Rad).

Single-cell electroporation {#s4-6}
---------------------------

After 3--4 days in culture, organotypic slices were transferred to an artificial cerebrospinal fluid (ACSF) containing (in mM): 130 NaCl, 2.5 KCl, 2.2 CaCl~2~, 1.5 MgCl~2~, 10 D-glucose, 10 HEPES (pH 7.35, osmolarity adjusted to 300 mOsm). CA1 pyramidal cells were then processed for single-cell electroporation using glass micropipets containing plasmids encoding TdTomato (6 ng/µL) and optoFGFR1 (13 ng/µL). For rescue experiments, a plasmid carrying the Nlgn1 specific shRNA (13 ng/µL) was electroporated along with a resistant AP-Nlgn1 or Y782F mutant (13 ng/µL), BirA^ER^ (6 ng/µL), TdTomato (6 ng/µL) and optoFGFR1 (13 ng/µL). Micropipets were pulled from 1 mm borosilicate capillaries (Harvard Apparatus) with a vertical puller (Narishige). Electroporation was performed by applying four square pulses of negative voltage (−2.5 V, 25 ms duration) at 1 Hz, then the pipet was gently removed. 10--20 neurons were electroporated per slice, and the slice was placed back in the incubator for 2--3 days before electrophysiology or confocal imaging.

Immunohistochemistry {#s4-7}
--------------------

For visualization of recombinant AP-Nlgn1 and spine morphology in electroporated CA1 neurons expressing tdTomato, AP-Nlgn1 and BirA^ER^, organotypic slices were fixed with 4% paraformaldehyde- 4% sucrose in PBS for 4 hr before the permeabilization of membranes with 0.25% Triton in PBS. Slices were subsequently incubated with NeutrAvidin (1:200, Invitrogen, A2226) conjugated to NHS-ester ATTO 647N (ATTO-TEC GmbH, AD 647 N-31) for 2 hr at room temperature. For visualization of HA-tagged optoFGFR1, fixed and permeabilized slices were incubated with rat anti-HA (Roche, clone 3F10, 1:100) overnight at 4°C. Slices were subsequently incubated with Alexa647-conjugated goat anti-rat antibody (Molecular Probes, 1:200) for 2 hr at room temperature.

Confocal microscopy and spine counting {#s4-8}
--------------------------------------

For fixed slices, images of single CA1 electroporated neurons co-expressing tdTomato, BirA^ER^ and AP-Nlgn1 (WT or Y782F mutant) were acquired on a commercial Leica DMI6000 TCS SP5 microscope using a 63x/1.4 NA oil objective and a pinhole opened to one time the Airy disk. Images of 4096 × 4096 pixels, giving a pixel size of 70 nm, were acquired at a scanning frequency of 400 Hz. The number of optical sections was between 150--200, using a vertical step size of 0.3--0.4 µm. The number of spines per unit dendrite length of tdTomato-positive cells in secondary and tertiary apical dendrites was calculated manually using Metamorph (Molecular Devices).

To assess the effect of optoFGFR1 stimulation on the formation of dendritic spines, we took confocal stacks of the dendritic tree of several CA1 neurons before light stimulation, then exposed the organotypic slices to dim 470 nm light pulses (1 s pulse every 2 s, 2.5 µW/mm²) through the LED array placed in the incubator for 24 hr, and finally took another round of images of the same neurons. For such time-lapse imaging, short imaging sessions (10--15 min) of live electroporated slices were carried out with a commercial Leica DMI6000 TCS SP5 microscope using a 63x/0.9 NA dipping objective and a pinhole opened to one time the Airy disk. Slices were maintained in HEPES-based ACSF. Laser intensity in all these experiments was kept at a minimum and acquisition conditions remained similar between the two imaging sessions. 12-bit images of 1024 × 1024 pixels, giving a pixel size of 120 nm, were acquired at a scanning frequency of 400 Hz. The number of optical sections varied between 150 and 200, and the vertical step size was 0.3--0.4 µm. The number of spines per unit dendrite length of tdTomato-positive neurons was calculated manually in Metamorph.

Electrophysiological recordings {#s4-9}
-------------------------------

Whole-cell patch-clamp recordings were carried out at room temperature in CA1 neurons from organotypic hippocampal cultures, placed on a Nikon Eclipse FN1 upright microscope equipped with a motorized stage and two manipulators (Scientifica). CA1 pyramidal neurons were imaged with DIC and electroporated neurons were identified by visualizing the GFP or Tdtomato fluorescence. The recording chamber was continuously perfused with ACSF bubbled with 95% O~2~/5% CO~2~ containing (in mM): 125 NaCl, 2.5 KCl, 26 NaHCO~3~, 1.25 NaH~2~PO~4~, 2 CaCl~2~, 1 MgCl~2~, and 25 glucose. 20 µM bicuculline and 100 nM NBQX were added to block inhibitory synaptic transmission and reduce epileptiform activity, respectively. The series resistance Rs was left uncompensated, and recordings with Rs higher than 30 MΩ were discarded. We measured both AMPA- and NMDA-receptor mediated EPSCs upon electrical stimulation of Schaffer's collaterals, using a double-patch clamp configuration to normalize the recordings with respect to a neighboring non-electroporated neuron ([@bib57]). Voltage-clamp recordings were digitized using the Multiclamp 700B amplifier (Axon Instruments) and acquired using the Clampex software (Axon Instruments). EPSCs and IPSCs were evoked in an electroporated neuron and a nearby non-electroporated neuron (control) every 10 s for 5 min using a bipolar electrode in borosilicate theta glass filled with ACSF and placed in the stratum radiatum or pyramidal layer; respectively. AMPAR-mediated currents were recorded at −70 mV and NMDAR-mediated currents were recorded at +40 mV and measured 50 ms after the stimulus, when AMPAR-mediated EPSCs are back to baseline. IPSCs were recorded at +10 mV and in the presence of 10 µM NBQX and 50 µM D-AP5 to block AMPARs and NMDARs, respectively. EPSCs and IPSCs amplitude measurements were performed using Clampfit (Axon Instruments).

For LTP recordings, ACSF contained in (mM) 125 NaCl, 2.5 KCl, 26 NaHCO~3~, 1.25 NaH~2~PO~4~, 4 CaCl~2~, 4 MgCl~2~, 25 glucose, and 0.02 bicuculline, while recording pipettes were filled with intracellular solution containing in mM: 125 Cs-MeSO~4~, 10 CsCl, 10 HEPES, 2.5 MgCl~2~, 4 Na~2~ATP, 0.4 NaGTP and 10 phosphocreatine. Axons from CA3 pyramidal cells were cut with a scalpel to prevent spontaneous action potential propagation. Slices were maintained at 25°C throughout the recording. Baseline AMPAR-mediated EPSCs were recorded every 10 s for 2 min before LTP induction. Then LTP was induced by depolarizing the cells to 0 mV while stimulating the afferent Schaffer's collaterals at 2 Hz for 100 s. Recordings were sampled at −70 mV every 10 s for 30 min after LTP induction. In some recordings, LTP was induced in presence of 50 µm D-AP5 to block NMDARs. Between the stimulations, spontaneous AMPAR-mediated EPSCs (sEPSCs) were also recorded. sEPSC amplitude, frequency, rise time and decay times were measured from averaged sEPSCs using miniAnalysis (Synaptosoft).

Computer simulations of AMPAR diffusion-trapping in LTP conditions {#s4-10}
------------------------------------------------------------------

The computer program is based on a previous framework describing the role of AMPAR membrane dynamics in synaptic plasticity ([@bib18]). Our original model included two types of processes to target AMPAR to synapses, that is diffusional trapping and vesicular recycling. However, based on recent experimental findings that hippocampal LTP primarily involves the diffusional trapping of extra-synaptic AMPARs ([@bib27]; [@bib52]), the current model focuses only on this process. Briefly, a dendritic segment is approximated by a 2D rectangular region (2 µm x 10 µm) containing five synapses (squares of 0.3 µm x 0.3 µm, surface area \~0.1 µm²), corresponding to a linear density of 0.5 synapse/µm as measured experimentally ([@bib42]). This area is populated with 1000 AMPARs, initially placed at random positions. AMPARs are characterized by their 2D coordinates x and y, over time, *t*. When AMPARs reach the region contours, rebound conditions are applied to keep them inside, that is the system is closed. At each time step (*∆t* = 100 ms), the coordinates are incremented by the distances Δx = (2D*∆t*)^1/2^ n~x~ and Δy = (2D*∆t*)^1/2^ n~y~, where n~x~ and n~y~ are random numbers generated from a normal distribution, and D is a diffusion coefficient which depends on whether AMPARs are outside (*D~out~* = 0.1 µm^2^/s) or inside (*D~in~* = 0.05 µm²/s) the synapse, values being taken from single molecule tracking experiments ([@bib49]). Lower AMPAR diffusion within the synaptic cleft is attributed to steric hindrance. To introduce a diffusion barrier at the synapse ([@bib24]), AMPARs are allowed to cross the synaptic border with a probability P~crossing~ = 0.5.

Within the synapse, AMPARs may reversibly bind to static post-synaptic density (PSD) components, namely PDZ domain containing scaffolding proteins including PSD-95, S-SCAM, PICK or GRIP, through the C-terminal PDZ motifs of GluA1/2, or of TARPs ([@bib3]; [@bib39]). To describe those dynamic interactions, we define two global parameters, the AMPAR/scaffold binding and unbinding rates (k~on~ = 1 s^−1^ and k~off~ = 0.04 s^−1^, respectively), obtained by previously fitting SPT and FRAP experiments ([@bib18]). AMPARs are allowed to stay in the PSD if the probability of binding in this time interval (*k~on~.∆t*) is greater than a random number between 0 and 1 generated from a uniform distribution. Otherwise, AMPARs continue to diffuse with coefficient *D~in~*. When bound to the PSD, AMPARs move with a lower diffusion coefficient *D~trap~* = 0.006 µm^2^/s, corresponding to confinement in the PSD ([@bib19]; [@bib49]). AMPARs stay in the PSD until their detachment probability (*k~off~.∆t*), exceeds another random number. Then, AMPARs can bind the same PSD again or escape into the extra-synaptic space. At steady state (reached for *t* \> 1/k~off~), there is a dynamic equilibrium between synaptic and extra-synaptic AMPARs. The enrichment ratio between synaptic and extra-synaptic AMPAR density is given by the formula: P~crossing~ (D~out~/D~in~) (1 + k~on~/k~off~). The maximal theoretical number of AMPARs per synapse is 200, when all extra-synaptic receptors in the system have been captured (given the excess of scaffolds versus AMPARs, we do not impose a saturation of binding sites here). With the chosen parameters however, there are about 30 AMPARs per synapse at basal state in control conditions, close to experimental measurements made by super-resolution imaging and freeze-fracture EM ([@bib43]; [@bib56]). The effect of Nlgn1 tyrosine phosphorylation on basal synaptic AMPAR levels was simulated by raising the AMPAR/scaffold binding rate (k~on~), thereby mimicking an increase in the steady-state number of average post-synaptic AMPAR trapping slots observed experimentally ([@bib25]; [@bib42]; [@bib47]).

To simulate LTP, the AMPAR/scaffold unbinding rate (k~off~) was decreased at time zero from higher (0.02 to 0.08 s^−1^) to lower values (0.002--0.006 s^−1^), hereby mimicking a higher affinity of TARPs to PSD-95 induced by CamKII activation ([@bib31]; [@bib51]). When we tried instead to simulate LTP by raising the parameter k~on~ at time zero, the predicted time course was much more rapid than the one observed experimentally (i.e. the plateau was reached in about one minute). Thus, that type of mechanism is not likely to operate in the particular LTP protocol used here. The total length of the trajectories was set to 35 min, including a 5 min baseline, to match the whole duration of LTP experiments. Ten simulations were generated for each type of condition, and the number of AMPARs per synapse was determined and averaged (sem is within 1% of the mean). To determine the theoretical relationship between LTP level and basal synaptic AMPARs content, the parameter k~on~ was varied between 0.075 s^−1^ and 10 s^−1^, thus simulating synapses that contain less or more AMPARs, respectively. We provide here as a supplemental text file the original Mathematica source code described earlier to simulate LTP experiments ([@bib18]). However, the algorithm used to make the simulations in this paper is part of a new, integrated software called FluoSim, which is submitted elsewhere ([@bib41]) and whose source code will be made freely available through *github* once published.

Sampling and statistics {#s4-11}
-----------------------

For the analysis of dendritic spines observed by confocal microscopy, N et n values represent the total number of cells and dendrites, respectively. For each experiment, three to four independent dissections (from two to three animals) were used. Sample sizes were determined according to previous studies ([@bib42]; [@bib57]).

Summary statistics are presented as mean ± SEM (Standard Error of the Mean), including individual data points. Statistical significance tests were performed using GraphPad Prism software (San Diego, CA). Test for normality was performed with D'Agostino and Pearson omnibus normality test. Paired data obtained by imaging or electrophysiology experiments were compared using the Wilcoxon matched-pairs signed rank test when criteria for normality were not met. When paired data followed a normal distribution, we used a paired t-test. The non-electroporated neuron serves as a paired control, since it is patched simultaneously as the electoporated neuron and receives the same input fibers and stimulation. ANOVA test was used to compare means of several groups of normally distributes variables. Kruskal-Wallis test was used to compare several groups showing non-normal distributions. Dunn's multiple comparisons post hoc test was then used to determine the p value between two conditions. Statistical significance was assumed when p\<0.05. In the figures, \*p\<0.05, \*\*p\<0.01, \*\*\*p\<0.001, \*\*\*\*p\<0.0001.
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In the interests of transparency, eLife publishes the most substantive revision requests and the accompanying author responses.

**Acceptance summary:**

The authors demonstrate the impact of an elegant technique, using light-induced phosphorylation of neuroligin-1 to gauge the impact of endogenous neuroligin-1 on synaptic function and plasticity in organotypic cultures of hippocampal CA1 neurons. This is an important advance for the field, answering fundamental issues and opening the door to new experiments to be pursued in the future.

**Decision letter after peer review:**

Thank you for submitting your article \"Optogenetic control of excitatory post-synaptic differentiation through neuroligin-1 tyrosine phosphorylation\" for consideration by *eLife*. Your article has been reviewed by three peer reviewers, and the evaluation has been overseen by a Reviewing Editor and Gary Westbrook as the Senior Editor. The following individual involved in review of your submission has agreed to reveal their identity: Markus Missler (Reviewer \#1).

Summary:

Three reviewers have read, reviewed and discussed your work. All three appreciate the novelty and importance of the work, a view that is shared by the reviewing editor. The authors demonstrate the impact of light-induced phosphorylation of neuroligin-1 on synaptic function in organotypic cultures of hippocampal CA1 neurons. They report that Nlgn1 phosphorylation at residue Y782 enhances AMPA receptor mediated excitatory PSCs and increases dendritic spine density. In addition, they find reduced LTP levels upon phosphorylation, which they explain by trapping AMPAR in the synapse at the cost of depleting extrasynaptic AMPAR populations. Together, this study confirms key findings and concepts from previous papers (Giannone et al., 2013; Letellier et al., 2018) that examined manipulations of the Nlgn gene and protein. The strong point of the current manuscript is the successful use of an elegant, state-of-the-art method of light-induced phosphorylation and the fact that they address for the first time, at least in the majority of experiments, effects are observed in the background of endogenous Nlgn expression levels. All reviewers consider the work sufficiently novel and relevant for eventual publication in *eLife* if the authors are able to address major concerns outlined below. It is the general opinion of the reviewers that this additional work is within the scope of the two month window required by *eLife*, and would not necessitate generation of any new reagents. The additional work would provide essential controls for the final LTP experiments, and are therefore considered essential.

Essential Revisions:

1\) The LTP data under optogenetically induced phosphorylation needs to contain at least the Nlgn1 KO or shRNA control under light condition to prove that abolishment of LTP is in fact due to the phosphorylation of Nlgn1. The authors have included this control for other phenotypic observations (AMPAR EPSCs, dendritic spines) but the LTP experiment should include at least one of these control conditions as well.

2\) Figure 4B) It is not well explained why a statistical test for paired data sets can be used here since it does not represent the same cells before and after light induction.

3\) In a previous paper, authors showed that overexpression of Nlg1 WT and Nlg1 Y782A but not Nlg1 Y782F affect AMPAR-EPSCs (Lettellier et al., 2018), but here in a replacement system, Nlg1 WT and Y782F do not have a significant effect on AMPAR EPSC. Can the authors discuss? Further, can the authors make comparisons with the previously published work more transparent?

4\) Figure 3E and F. comparisons between different conditions should be added, or the authors can state why such comparisons are not necessary.

5\) Nlg1 KO has been shown to decrease NMDAR-EPSC, but here the authors did not see a decrease. This discrepancy with the literature should be acknowledged and commented upon in the text.

10.7554/eLife.52027.sa2

Author response

> Essential Revisions:
>
> 1\) The LTP data under optogenetically induced phosphorylation needs to contain at least the Nlgn1 KO or shRNA control under light condition to prove that abolishment of LTP is in fact due to the phosphorylation of Nlgn1. The authors have included this control for other phenotypic observations (AMPAR EPSCs, dendritic spines) but the LTP experiment should include at least one of these control conditions as well.

To answer this point, we performed LTP experiments in organotypic slices from Nlgn1 KO mice, under the same protocol as for slices from WT animals. We first verified using the pharmacological inhibitor AP5 that the elicited LTP was NMDAR-dependent (Figure 5---figure supplement 1A). Importantly, light stimulation of optoFGFR1 did not alter LTP in Nlgn1 KO neurons (Figure 5 C, D), indicating that Nlgn1 phosphorylation is responsible for the decreased LTP in wild type neurons. This is in agreement with the fact that light activation of optoFGFR1 does not affect basal EPSC amplitude in Nlgn1 KO neurons (Figure 3D, F), and is therefore not predicted to alter LTP according to our simulations.

However, we were surprised to find that Nlgn1 KO neurons exhibited similar LTP magnitude compared to control neurons from wild type slices, despite a decreased NMDA/AMPA ratio (**see response to major comment \#5**). The discrepancy between these results and previous studies using Nlgn1 knock-out or knock-down approaches (Jiang et al., 2017; Wu et al., 2019; Budreck et al., 2013; Kim et al., 2008), is unclear and will require further investigation, which we think are beyond the scope of this study. Nevertheless, one or several possible explanations can be proposed:

1\) the model (acute slices vs. organotypic slices): Studies using acute slices (e.g., Jiang et al., 2017; Kim et al., 2008; Wu et al., 2019) all found a full blockade of NMDAR-dependent LTP at CA3-CA1 synapses in the absence of Nlgn1. However, Budreck et al., 2013, reported in organotypic slices that NMDAR-LTP was not fully blocked, at least in the early stages (Figure 5: first 10-20 min after the stimulation).

2\) the stimulation protocol (tetanus vs. pairing): We used a protocol similar to Budreck et al. (2 Hz stimulation with the post-synaptic cell @ 0 mV under voltage-clamp) but delivered 200 pulses instead of 100. Given that Budreck et al. found some potentiation in the initial stages of LTP (unlike studies using high frequency stimulations in acute slices), It is possible that our prolonged stimulation allowed to reach the threshold which is necessary to activate downstream signaling.

3\) the neuronal maturation: Shipman et al., 2012, have shown that LTP induced by a tetanus at CA3-CA1 synapses is impaired in acute slices from young (P11-P14) but not mature animals (P40) when Nlgn1 is knocked-down with a miRNA-based approach. Although we performed our experiments in organotypic slices at DIV10-14, which would be closer to P11-P14, we cannot exclude that neuronal maturation is not altered in our slice model and affect the ability of neurons to undergo LTP.

> 2\) Figure 5B) It is not well explained why a statistical test for paired data sets can be used here since it does not represent the same cells before and after light induction.

We decided to use the Wilcoxon signed-rank test to compare the LTP magnitude between electroporated neurons vs. control neighbors because EPSCs in these neurons were recorded simultaneously under the same conditions, i.e., the same input fibers were stimulated. We therefore think that these data can be considered as paired (see also previous studies using the Wilcoxon signed-rank test or the paired t-test to compare data from "paired whole cell recordings": e.g., Shipman and Nicoll, Neuron 2012; Shipman et al., 2011; Watson et al., *eLife* 2017).

> 3\) In a previous paper, authors showed that overexpression of Nlg1 WT and Nlg1 Y782A but not Nlg1 Y782F affect AMPAR-EPSCs (Letellier et al., 2018), but here in a replacement system, Nlg1 WT and Y782F do not have a significant effect on AMPAR EPSC. Can the authors discuss? Further, can the authors make comparisons with the previously published work more transparent?

The reviewer is right to ask for a more transparent comparison of this study which uses optogenetic activation of Nlgn1 phosphorylation, with our previous study (Letellier et al., 2018) which relied mostly on the use of tyrosine point mutants (Y782A/F). Indeed, upon over-expression in slices from Nlgn1 KO mice, Nlgn1-WT and Nlgn1-Y782A increase AMPAR-mediated EPSCs by about 4 fold, which is related to the increase in the number of synaptic contacts containing PSD-95 and AMPARs, while Nlgn1 Y782F does not cause such an increase (only 2-fold, significantly lower than Nlgn1-WT and -Y782A), most likely because it is unable to recruit a proper excitatory scaffold and AMPARs in front of newly recruited glutamatergic terminals.

Under replacement conditions (shRNA to Nlgn1 + rescue Nlgn1 in slices from WT mice), Nlgn1-WT did not increase AMPAR-mediated EPSCs, as expected from a full functional replacement. In contrast, Nlgn1-Y782A increased AMPAR-EPSCs by 4-fold and fully blocked LTP, as compared with non-electroporated neurons (Letellier et al., 2018), most likely resulting from a saturating recruitment of post-synaptic AMPARs at preexisting synapses and not from an increase in the number of synaptic contacts. In this respect, Y782A can be considered as a *gain-of function* mutation. Finally, the *loss-of-function* mutation Nlgn1-Y782F did not decrease AMPAR-mediated EPSCs as compared to non-electroporated neurons or neurons re-expressing Nlgn1-WT, as might have been expected (Letellier et al., 2018 - Figure 6F), potentially because of compensatory mechanisms independent of Nlgn1 in already assembled synapses. However, the non-phosphorylatable Nlgn1-Y782F mutant also partially blocked LTP (Letellier et al., 2018 - Figure 6G, H), suggesting that an optimal level of Nlgn1 phosphorylation is important for synapse potentiation. Indeed, we show here that photo-stimulation of optoFGFR1 increases basal AMPAR-EPSCs and partially occludes LTP. The fact that the optoFGFR1 is not as efficient as Nlgn1-Y782A in these processes can be due to the fact that: i) the Nlgn1 phosphorylation is not maximal, or ii) that the phosphorylation is not as potent in inhibiting gephyrin binding as the Y782A mutation. We modified the Discussion (third paragraph) to make this comparison more explicit.

> 4\) Figure 4E and F. comparisons between different conditions should be added, or the authors can state why such comparisons are not necessary.

In addition to the Wilcoxon signed-rank test which shows a significant increase of EPSC amplitude in electroporated neurons expressing Nlgn1-WT and exposed to light relatively to their non electroporated counterparts, we have now added the comparisons between sets of paired data using the Kruskall-Wallis test, as requested by the reviewers (now Figure 4E). However, in contrast, to the data set comparing wild-type and knock-out slices in Figures 2D and 3F, we did not find any significant statistical difference between the conditions (WT vs. Y782F, light vs. dark). This might be explained by the higher variability in the data collected, which likely results from the replacement strategy in which the ratio between shRNA and recombinant Nlgn1 varies from cell to cell.

> 5\) Nlg1 KO has been shown to decrease NMDAR-EPSC, but here the authors did not see a decrease. This discrepancy with the literature should be acknowledged and commented upon in the text.

We thank the reviewers for this comment which allows us to clarify our results. In agreement with previous reports (Chubykin et al., 2007; Kwon et al., 2012, Jiang et al., 2017), we do find a decrease in the NMDA-to-AMPA ratio when comparing Nlgn1 KO (or knocked-down) with WT (or rescued) neurons from different slices (see Figure 5---figure supplement 1B). However, this comparison is not apparent in the graph plots from Figures 2 and 3, where EPSC amplitudes from electroporated cells have been normalized to control cells from the same slice (i.e., from the same genotype) to isolate the effect of optoFGFR1 activation alone. Therefore, in Figure 2E, one should read that light activation of optoFGFR1 fails to affect NMDAR currents in the electroporated neurons relatively to its control (whether WT or KO).
